Centessa Pharmaceuticals plc (CNTA)

NASDAQ: CNTA · Real-Time Price · USD

Compare

23.56

+0.01 (0.04%)

At close: Feb 11, 2026, 4:00 PM EST

23.91

+0.35 (1.49%)

After-hours: Feb 11, 2026, 6:51 PM EST

Centessa Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	50.81	383.22	128.03	393.64	595.08	7.23
Short-Term Investments	195.4	98.96	128.52	-	-	-
Cash & Short-Term Investments	246.21	482.18	256.55	393.64	595.08	7.23
Cash Growth	-52.51%	87.95%	-34.83%	-33.85%	8134.15%	-
Other Receivables	52.21	45.3	39.15	26.72	16.81	2.93
Receivables	52.21	45.3	39.15	26.72	16.81	2.93
Prepaid Expenses	1.26	0.84	1.65	2.79	4.66	0.01
Other Current Assets	7.99	8.1	17.74	14.59	12.22	1
Total Current Assets	307.68	536.41	315.09	437.75	628.77	11.17
Property, Plant & Equipment	11.19	11.76	12.95	1.17	0.16	-
Long-Term Deferred Tax Assets	25.02	26.59	29.65	3.51	-	-
Other Long-Term Assets	1.59	2.05	2.55	1.88	0.7	0.55
Total Assets	448.3	576.8	360.25	444.31	629.64	11.72
Accounts Payable	8.68	7.14	11.82	13.84	8.07	1.03
Accrued Expenses	19.39	49.31	26.62	22.23	15.7	1.04
Short-Term Debt	-	-	-	-	-	5.63
Current Portion of Leases	0.68	0.6	-	-	-	-
Current Income Taxes Payable	0.06	0.84	0.11	1.58	0.77	-
Other Current Liabilities	0.31	0.11	0.84	0.69	0.1	0.92
Total Current Liabilities	29.12	58	39.39	38.34	24.64	8.62
Long-Term Debt	109.82	108.94	75.7	69.8	75.7	-
Long-Term Leases	7.76	8.29	8.89	-	-	-
Other Long-Term Liabilities	0.03	0.03	0.03	-	37.74	-
Total Liabilities	146.73	175.25	124	108.14	138.08	8.62
Common Stock	0.36	0.36	0.27	0.27	0.25	25.55
Additional Paid-In Capital	1,419	1,386	987.42	939.26	876.27	0.83
Retained Earnings	-1,120	-988.7	-752.95	-601.86	-385.65	-23.85
Comprehensive Income & Other	2.6	4.21	1.49	-1.5	0.69	0.57
Shareholders' Equity	301.57	401.55	236.24	336.17	491.55	3.1
Total Liabilities & Equity	448.3	576.8	360.25	444.31	629.64	11.72
Total Debt	118.26	117.83	84.59	69.8	75.7	5.63
Net Cash (Debt)	127.96	364.35	171.96	323.84	519.38	1.6
Net Cash Growth	-70.50%	111.88%	-46.90%	-37.65%	32361.38%	-
Net Cash Per Share	0.96	3.18	1.79	3.47	6.91	0.11
Filing Date Shares Outstanding	134.45	133.18	100.31	94.96	94.02	15
Total Common Shares Outstanding	134.42	132.63	98.77	94.84	89.99	15
Working Capital	278.55	478.41	275.71	399.41	604.14	2.55
Book Value Per Share	2.24	3.03	2.39	3.54	5.46	0.21
Tangible Book Value	301.57	401.55	236.24	336.17	491.55	3.1
Tangible Book Value Per Share	2.24	3.03	2.39	3.54	5.46	0.21
Machinery	1.86	1.54	1.5	0.44	0.2	-
Construction In Progress	-	-	-	0.89	-	-

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q